JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$4.16B |
| 2 |
Microsoft
MSFT
|
+$2.29B |
| 3 |
Amazon
AMZN
|
+$2B |
| 4 |
UnitedHealth
UNH
|
+$1.76B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.42B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.61B |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.58B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$689M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$659M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.03% |
| 2 | Healthcare | 12.52% |
| 3 | Financials | 10.5% |
| 4 | Consumer Discretionary | 7.88% |
| 5 | Industrials | 7.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VBNK
4901
VersaBank
VBNK
$647M
| $178K | ﹤0.01% |
24,400
-400
| -2% | -$3.72K |
|
4902
Algoma Steel Group Warrant
ASTLW
$222K
| – | – |
0
| – | – |
|
4903
iShares Bloomberg Roll Select Commodity Strategy ETF
CMDY
$575M
| $177K | ﹤0.01% |
3,037
-3,826
| -56% | -$244K |
|
|
CTLP
4904
DELISTED
Cantaloupe
CTLP
| $176K | ﹤0.01% |
31,469
+3,903
| +14% | +$20.7K |
|
4905
Johnson Outdoors
JOUT
$512M
| $176K | ﹤0.01% |
2,876
-25,805
| -90% | -$1.79M |
|
|
CPE
4906
CALL
DELISTED
Callon Petroleum Company
CPE
| $176K | ﹤0.01% |
4,500
| – | – |
|
4907
WisdomTree US SmallCap Earnings Fund
EES
$736M
| $175K | ﹤0.01% |
4,266
+604
| +16% | +$26.9K |
|
4908
Kiniksa Pharmaceuticals
KNSA
$6.07B
| $175K | ﹤0.01% |
18,173
+348
| +2% | +$3.25K |
|
4909
Intapp
INTA
$3.16B
| $174K | ﹤0.01% |
11,837
+2,132
| +22% | +$44.8K |
|
4910
Arbutus Biopharma
ABUS
$906M
| $173K | ﹤0.01% |
64,191
+5,265
| +9% | +$13.5K |
|
4911
WisdomTree US MidCap Fund
EZM
$960M
| $173K | ﹤0.01% |
3,770
+559
| +17% | +$28.3K |
|
4912
Tejon Ranch
TRC
$443M
| $173K | ﹤0.01% |
11,207
-4,576
| -29% | -$78.9K |
|
|
OSG
4913
DELISTED
Overseas Shipholding Group Inc.
OSG
| $172K | ﹤0.01% |
83,923
-111,313
| -57% | -$239K |
|
4914
Distribution Solutions Group
DSGR
$1.61B
| $171K | ﹤0.01% |
6,658
-370
| -5% | -$7.71K |
|
4915
Monte Rosa Therapeutics
GLUE
$1.35B
| $171K | ﹤0.01% |
17,708
-4,804
| -21% | -$48.3K |
|
4916
iShares US Broker-Dealers & Securities Exchanges ETF
IAI
$1.39B
| $171K | ﹤0.01% |
+2,032
| New | +$183K |
|
4917
NewtekOne
NEWT
$378M
| $171K | ﹤0.01% |
9,030
+5,165
| +134% | +$124K |
|
4918
Aegon
AEG
$13.9B
| $170K | ﹤0.01% |
39,948
+29,202
| +272% | +$145K |
|
4919
PUT
FerroAtlántica
GSM
$818M
| $170K | ﹤0.01% |
+28,600
| New | +$201K |
|
4920
Vitamin Cottage Natural Grocers
NGVC
$646M
| $170K | ﹤0.01% |
10,691
+6,361
| +147% | +$118K |
|
4921
Edgewise Therapeutics
EWTX
$4.69B
| $168K | ﹤0.01% |
21,109
-6,057
| -22% | -$45.8K |
|
4922
State Street SPDR S&P 600 Small Cap Growth ETF
SLYG
$5.23B
| $168K | ﹤0.01% |
2,377
-43
| -2% | -$3.26K |
|
4923
Daily Journal
DJCO
$828M
| $167K | ﹤0.01% |
646
+78
| +14% | +$21K |
|
4924
VanEck CEF Muni Income ETF
XMPT
$221M
| $167K | ﹤0.01% |
+7,245
| New | +$169K |
|
4925
Astronics
ATRO
$4.57B
| $165K | ﹤0.01% |
19,573
-212,644
| -92% | -$1.92M |
|
Similar funds
JP Morgan Chase's Q2 2022 Portfolio in Review
As of Q2 2022, JP Morgan Chase held 7,270 positions worth $718B, down 14% from $830B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2022 filing shows 568 new, 2,561 increased, 2,729 reduced and 610 closed positions. Its largest new stake was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $4.61B.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q2 2022 buy was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B.
- JP Morgan Chase added most to Microsoft in Q2 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q2 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $4.61B.
- JP Morgan Chase fully exited Cerner Corp in Q2 2022, selling an estimated $608M.
- JP Morgan Chase's ten largest holdings make up 18% of its $718B portfolio in Q2 2022.
- JP Morgan Chase opened 568 new positions and closed 610 in Q2 2022.
- JP Morgan Chase's portfolio value fell 14% quarter-over-quarter to $718B.
Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.